These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease. Noetzli M; Eap CB Clin Pharmacokinet; 2013 Apr; 52(4):225-41. PubMed ID: 23408070 [TBL] [Abstract][Full Text] [Related]
3. Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer's dementia using OMOP CDM. Byun J; Lee DY; Jeong CW; Kim Y; Rhee HY; Moon KW; Heo J; Hong Y; Kim WJ; Nam SJ; Choi HS; Park JI; Chun IK; Bak SH; Lee K; Byeon GH; Kim KL; Kim JA; Park YJ; Kim JH; Lee EJ; Lee SA; Kwon SO; Park SW; Kasani PH; Kim JK; Kim Y; Kim S; Jang JW Sci Rep; 2022 Mar; 12(1):4451. PubMed ID: 35292697 [TBL] [Abstract][Full Text] [Related]
4. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model. Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366 [TBL] [Abstract][Full Text] [Related]
5. [Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine]. Sicras-Mainar A; Vergara J; Leon-Colombo T; Febrer L; Rejas-Gutierrez J Rev Neurol; 2006 Oct 16-31; 43(8):449-53. PubMed ID: 17033976 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Alzheimer's disease in the long-term-care setting. Smith DA Am J Health Syst Pharm; 2009 May; 66(10):899-907. PubMed ID: 19420308 [TBL] [Abstract][Full Text] [Related]
7. Evaluating the efficacy and safety of Alzheimer's disease drugs: A meta-analysis and systematic review. Chen Y; Lai M; Tao M Medicine (Baltimore); 2024 Apr; 103(16):e37799. PubMed ID: 38640313 [TBL] [Abstract][Full Text] [Related]
8. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis. Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P Drugs Aging; 2019 May; 36(5):435-452. PubMed ID: 30937879 [TBL] [Abstract][Full Text] [Related]
9. Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials? Ehret MJ; Chamberlin KW Clin Ther; 2015 Aug; 37(8):1604-16. PubMed ID: 26122885 [TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapeutic approaches to the treatment of Alzheimer's disease. Standridge JB Clin Ther; 2004 May; 26(5):615-30. PubMed ID: 15220008 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease. Marucci G; Buccioni M; Ben DD; Lambertucci C; Volpini R; Amenta F Neuropharmacology; 2021 Jun; 190():108352. PubMed ID: 33035532 [TBL] [Abstract][Full Text] [Related]
13. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. O'Brien JT; Holmes C; Jones M; Jones R; Livingston G; McKeith I; Mittler P; Passmore P; Ritchie C; Robinson L; Sampson EL; Taylor JP; Thomas A; Burns A J Psychopharmacol; 2017 Feb; 31(2):147-168. PubMed ID: 28103749 [TBL] [Abstract][Full Text] [Related]
14. Effective pharmacological management of Alzheimer's disease. Atri A Am J Manag Care; 2011 Nov; 17 Suppl 13():S346-55. PubMed ID: 22214392 [TBL] [Abstract][Full Text] [Related]
15. [Current approaches to optimize treatment of dementia and Alzheimer's disease]. Kolykhalov IV Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(6):87-92. PubMed ID: 28635795 [TBL] [Abstract][Full Text] [Related]
16. Challenges and Approaches of Drugs Such as Memantine, Donepezil, Rivastigmine, and Aducanumab in the Treatment, Control and Management of Alzheimer's Disease. Saeedi M; Mehranfar F Recent Pat Biotechnol; 2022; 16(2):102-121. PubMed ID: 35236274 [TBL] [Abstract][Full Text] [Related]